Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Shanghai MicroPort EP Medtech Co's 5-Year Yield-on-Cost % or its related term are showing as below:
SHSE:688351'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0.12
Current: 0.11
During the past 11 years, Shanghai MicroPort EP Medtech Co's highest Yield on Cost was 0.12. The lowest was 0.00. And the median was 0.00.
SHSE:688351's 5-Year Yield-on-Cost % is ranked worse than 97.46% of 315
companies
in the Medical Devices & Instruments industry
Industry Median: 2.43
vs SHSE:688351: 0.11
Shanghai MicroPort EP Medtech Co (SHSE:688351) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Shanghai MicroPort EP Medtech Co 5-Year Yield-on-Cost % Related Terms
SHSE:688351 vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Shanghai MicroPort EP Medtech Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai MicroPort EP Medtech Co 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai MicroPort EP Medtech Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Shanghai MicroPort EP Medtech Co's 5-Year Yield-on-Cost % falls into.
Shanghai MicroPort EP Medtech Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Shanghai MicroPort EP Medtech Co (SHSE:688351) has a 5-Year Yield-on-Cost % of 0.11 as of Aug. 28, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Shanghai MicroPort EP Medtech Co and its competitors. According to the industry distribution chart, Shanghai MicroPort EP Medtech Co ranks #307 out of 315 companies in the Medical Devices & Instruments industry, placing it in the top 97.5%.
Is Shanghai MicroPort EP Medtech Co's 5-Year Yield-on-Cost % too high?
Shanghai MicroPort EP Medtech Co's current 5-Year Yield-on-Cost % is 0.11. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.43. Shanghai MicroPort EP Medtech Co's value of 0.11 is 95.5% below this industry median. Based on the distribution chart, Shanghai MicroPort EP Medtech Co ranks #307 out of 315 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Shanghai MicroPort EP Medtech Co has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai MicroPort EP Medtech Co's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai MicroPort EP Medtech Co ranks #307 out of 315 companies for 5-Year Yield-on-Cost %. This places Shanghai MicroPort EP Medtech Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.43. Shanghai MicroPort EP Medtech Co's value of 0.11 is 95.5% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.43, based on 315 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai MicroPort EP Medtech Co's current 5-Year Yield-on-Cost % of 0.11 is 95.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Shanghai MicroPort EP Medtech Co and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.43 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai MicroPort EP Medtech Co's current 5-Year Yield-on-Cost % is 0.11. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai MicroPort EP Medtech Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai MicroPort EP Medtech Co (SHSE:688351) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥27.90, compared to a current price of ¥18.19 — trading 34.8% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.11 and 95.5% below the Medical Devices & Instruments industry median of 2.43. Shanghai MicroPort EP Medtech Co's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Shanghai MicroPort EP Medtech Co (SHSE:688351), the current 5-Year Yield-on-Cost % is 0.11 as of Aug. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai MicroPort EP Medtech Co (SHSE:688351) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai MicroPort EP Medtech Co stock appears to be undervalued.
The current stock price of ¥18.19 is trading 34.8% below its estimated GF Value™ of ¥27.90.
GuruFocus considers Shanghai MicroPort EP Medtech Co to be Significantly Undervalued.
Key valuation signals for SHSE:688351:
5-Year Yield-on-Cost %: 0.11
GF Value™: ¥27.90 vs. price of ¥18.19 (34.8% below fair value)
Industry Position: 95.5% below the Medical Devices & Instruments median (#307 of 315)
No single metric tells the full story. See the SHSE:688351 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai MicroPort EP Medtech Co Ltd is engaged in the research, development, production and sales of various medical devices and equipment related to cardiac electrophysiology interventional diagnosis and treatment.
76GF Score
Get the complete analysis for SHSE:688351
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688351 has been successfully added to your 
